INCOZEN THERAPEUTICS

Incozen Therapeutics Pvt, Ltd., is headquartered in Hyderabad, India. The company’s primary focus is the development and commercialization of oncotherapies and aims to foster partnerships and collaborations with pharmaceutical companies across the globe. Led by a team of experienced individuals, the company aims to leverage its combined strength in preclinical discovery, formulation development, and clinical research to become a major player in the oncology space. With a team of top notch scie... ntists equipped with years of experience in cancer research spread across preclinical discovery, formulation development, and clinical research, Incozen hopes to come up with exciting therapeutic options for potential clinical evaluation in regions across Asia, Europe, and Australia. Incozen’s affiliate, Rhizen Pharmaceuticals SA, is located in Switzerland with an associate arm in the USA and manages business development outreach and licensing for the North American and European markets Incozen is an affiliate company of Alembic Pharmaceuticals Ltd, one of India’s oldest and leading multi-national publicly-listed conglomerate with businesses across pharmaceuticals, glass, chemicals, real estate, engineering, education and healthcare domains. Alembic’s pharmaceutical business has a global footprint (both operations and commercial); capabilities spanning API, generics & specialty products and a proven track record of regulatory and commercial success across all the major markets. Incozen, Rhizen, and Alembic’s shared vision and common representation at the board and investor level, has allowed optimal alignment of their strategy and operations for maximal mutual benefit.More